Results

Total Results: 3,981 records

Showing results for "cardiovascular".
Users also searched for: statin

  1. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2014chartbooks/hispanichealth/2014nhqdr-hispanichealth-pt3.pptx
    September 19, 2015 - most effective prevention and treatment practices for the leading causes of mortality, starting with cardiovascular
  2. hcup-us.ahrq.gov/reports/statbriefs/sb245-Substance-Inpatient-Stays-Across-US-Counties.pdf
    February 01, 2018 - substance use disorder are at greater risk of major medical conditions and adverse outcomes such as cardiovascular
  3. hcup-us.ahrq.gov/reports/methods/2008_07.pdf
    January 01, 2008 - Examples include: health status, immunization, diabetes, tobacco use, HIV/AIDS, arthritis, asthma, and cardiovascular
  4. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2022qdr-appendix-combined.pdf
    October 25, 2022 - • From 2000 to 2020, 83% of cancer measures, 14% of cardiovascular disease measures, 20% of chronic … • From 2000 to 2020, 14% of cardiovascular disease measures, 14% of diabetes measures, and 60% of mental
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/s9Hht_QpMB4gQg26rTpcaN
    November 01, 2013 - Comparative cardiovascular safety of dementia medications: a cross-national study. … decline (i.e., donepezil, galantamine, rivastigmine, and memantine) and medications primarily aimed at cardiovascular
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
    March 01, 2013 - of extended-release oxybutynin or Tolterodine would present undue risk (medically uncontrolled cardiovascular … agents or drugs for the treatment of Parkinson’s disease, anti-arrhythmic), serious life threatening cardiovascular
  7. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2015Q1Q3_IP_MaskedStats.PDF
    October 01, 2014 - 0.04 61: Other OR procedures on vessels other than head and neck 21,604 0.68 62: Other diagnostic cardiovascular … procedures 1,475 0.05 63: Other non-OR therapeutic cardiovascular procedures 11,786 0.37 64: Bone
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_executive.pdf
    April 01, 2014 - of adverse effects of OMBP are the elderly (≥65 years of age) and those with comorbidities such as cardiovascular
  9. effectivehealthcare.ahrq.gov/sites/default/files/cultural-competence_disposition-comments.pdf
    January 01, 2020 - risk factors and social determinants of health related to chronic conditions such as diabetes and cardiovascular
  10. hcup-us.ahrq.gov/db/nation/nass/2017_NASS_Introduction.pdf
    January 01, 2017 - dialysis 061 Other OR procedures on vessels other than head and neck 063 Other non-OR therapeutic cardiovascular
  11. digital.ahrq.gov/sites/default/files/docs/publication/u18hs016394-lapane-final-report-2006.pdf
    January 01, 2006 - notification that a patient has NOT picked up a prescription, more than half of clinicians indicated that cardiovascular
  12. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2014chartbooks/hispanichealth/2014nhqdr-hispanichealth-pt3.pdf
    June 01, 2014 - most effective prevention and treatment practices for the leading causes of mortality, starting with cardiovascular
  13. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-131-fullreport.pdf
    April 05, 2017 - example, a measure addressing childhood obesity may have implications for the subsequent development of cardiovascular
  14. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-145-fullreport.pdf
    July 01, 2016 - example, a measure addressing childhood obesity may have implications for the subsequent development of cardiovascular
  15. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-fullreport.pdf
    December 17, 2019 - example, a measure addressing childhood obesity may have implications for the subsequent development of cardiovascular
  16. www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
    February 02, 2012 - Cardiovascular monitor- ing and stimulant drugs for attention- deficit/hyperactivity disorder.
  17. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-202-fullreport.pdf
    January 01, 2014 - example, a measure addressing childhood obesity may have implications for the subsequent development of cardiovascular
  18. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-136-fullreport.pdf
    July 01, 2018 - example, a measure addressing childhood obesity may have implications for the subsequent development of cardiovascular
  19. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-144-fullreport.pdf
    January 01, 2020 - example, a measure addressing childhood obesity may have implications for the subsequent development of cardiovascular
  20. www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
    February 02, 2012 - Cardiovascular monitor­ ing and stimulant drugs for attention­ deficit/hyperactivity disorder.